Rotterdam, Leiden, Maastricht, Houten, Amsterdam, and Enschede, The Netherlands
From the Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute University Medical Center Rotterdam; the Dutch Institute for Clinical Auditing, Dutch Breast Implant Registry; the Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre; the Dutch Nationwide Network and Registry of Histo- and Cytopathology; the Departments of Medical Oncology and Epidemiology and Biostatistics, Netherlands Cancer Institute; the Department of Pathology, Amsterdam University Medical Center, VU University Medical Centre; and the Department of Plastic, Reconstructive, and Hand Surgery, Ziekenhuis Groep Twente/Medisch Spectrum Twente.
Received for publication May 31, 2018; accepted August 28, 2018.
The first two authors and the last two authors contributed equally to this article.
Disclosure:None of the authors has a financial interest in any of the products or devices mentioned in this article.
By reading this article, you are entitled to claim one (1) hour of Category 2 Patient Safety Credit. ASPS members can claim this credit by logging in to PlasticSurgery.org Dashboard, clicking “Submit CME,” and completing the form.
Hinne A. Rakhorst, M.D., Ph.D., Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands, [email protected]
